Comparison of enhancing effects of different goitrogen treatments in combination with β-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estogenic compounds

Cancer Science

Volumn 97, Issue 1, 2006, Pages 25-31

  Takizawa, Tamotsu ^a   Imai, Toshio ^a   Ueda, Makoto ^a   Onodera, Hiroshi ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BIS(2 HYDROXYPROPYL)NITROSAMINE; ESTRADIOL BENZOATE; IOPANOIC ACID; POTASSIUM PERCHLORATE; PROPYLTHIOURACIL; SULFADIMETHOXINE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HISTOPATHOLOGY; INCIDENCE; IODINE DEFICIENCY; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS; THYROID CANCER; THYROID HORMONE BLOOD LEVEL; TUMOR GROWTH;

ANIMALS; ANTITHYROID AGENTS; BODY WEIGHT; CARCINOGENICITY TESTS; CELL TRANSFORMATION, NEOPLASTIC; ESTRADIOL; ESTROGENS; FEMALE; MODELS, ANIMAL; MOLECULAR STRUCTURE; ORGAN SIZE; OVARIECTOMY; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; THYROID NEOPLASMS; TIME FACTORS;

EID: 32944459444     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00132.x     Document Type: Article

References (32)

1. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982; 42: 3232-9.
2. Ron E, Kleinerman RA, Boice Jr JD, LiVolsi VA, Flannery JT, Fraumeni Jr JF. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987; 79: 1-12.
3. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions. Pol J Pathol 2002; 53: 67-72.
4. Yane K, Kitahori Y, Konishi N et al. Expression of estrogen receptor in human thyroid neoplasms. Cancer Lett 1994; 84: 59-66.
5. Mori M, Naito M, Watanabe H, Takeichi N, Dohi K, Ito A. Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. Cancer Res 1990; 50: 7662-7.
6. Shirai T, Tsuda H, Ogiso T, Hirose M, Ito N. Organ specific modifying potential of ethynyl estradiol on carcinogenesis initiated with different carcinogens. Carcinogenesis 1987; 8: 115-9.
7. Son H, Nishikawa A, Ikeda T, Furukawa F, Hirose M. Lack of modification by environmental estrogenic compounds of thyroid carciniogenesis in ovariectomized rats pretreated with N-bis (2-hydroxypropyl) nitrosamine (DHPN). Jpn J Cancer Res 2000; 91: 966-72.
8. Ito N, Tsuda T, Tatematsu M et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for new medium term bioassay system. Carcinogenesis 1988; 9: 387-94.
9. Ito N, Tamano S, Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 2003; 94: 3-8.
10. Onose J, Imai T, Hasumura M, Ueda M, Hirose M. Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment. Cancer Lett 2003; 198: 145-52.
11. Liu ES, Ye YN, Shin VY, Yuen ST, Leung SY, Wong BC. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003; 24: 1407-13.
12. Takagi H, Mitsumori K, Onodera H et al. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats. Cancer Lett 2002; 178: 1-9.
13. McClain RM. Thyroid gland neoplasia: non-genotoxic mechanisms. Toxicol Lett 1992; 64/65: 397-408.
14. Hill RN, Erdreich LS, Paytner OE, Roberts PA, Rosenthal SL, Wilkinson CF. Thyroid-follicular cell carcinogenesis. Fundam Appl Toxicol 1989; 12: 629-97.
15. Takayama S, Aihara K, Onodera T, Akimoto T. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. Toxicol Appl Pharmacol 1986; 82: 191-9.
16. St Germain DL, Croteau W. Ligand-induced inactivation of type I iodothyronine 5′-deiodinase: protection by propylthiouracil in vivo and reversibility in vitro. Endocrinology 1989; 125: 2735-44.
17. Silva JE, Gordon MB, Crantz FR, Leonard JL, Larsen PR. Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats. J Clin Invest 1984; 73: 898-907.
18. Capen CC. Mechanisms of chemical injury of thyroid gland. Prog Clin Biol Res 1994; 387: 173-91.
19. Wolff J. Perchlolate and thyroid gland. Pharmacol Rev 1998; 50: 89-105.
20. Ikeda T, Nishikawa A, Son HY et al. Synergistic effects of high-dose soybean intake with iodine deficiency, but not sulfadimethoxine or phenobarbital, on rat thyroid proliferation. Jpn J Cancer Res 2001; 92: 390-5.
21. Onodera H, Mitsumori K, Takahashi K et al. Thyroid proliferative lesions induced by anti-thyroid drugs in rats are not always accompanied by sustained increase in serum TSH. J Toxicol Sci 1994; 19: 227-34.
22. 4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat. Acta Endocri 1979; 91: 271-81.
23. Oberkotter LV. Effect of iopanoic acid on basal and thyrotropin-stimulated thyroid hormone levels in suckling rat pups. Life Sci 1990; 46: 1-7.
24. Takagi H, Mitsumori K, Onodera H et al. Modifying effects of endocrine disrupting chemicals on N-bis (2-hydroxypropyl) nitrosamine and sulfadimethoxine-induced thyroid carcinogenesis in rats. J Toxicol Pathol 2001; 14: 121-8.
25. Chen HJ, Walfish PG. Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology 1978; 103: 1023-30.
26. Yamada H, Gohyama N, Honda S, Hara T, Harada N, Oguri K. Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: assessment using aromatase-deficient mice. Toxicol Appl Pharmacol 2002; 180: 1-10.
27. Jager W, Correia MA, Bornheim LM et al. Ethynylestradiol-mediated induction of hepatic cyp3A9 in female rats: implantation for cyclosporine metabolism. Drug Meta Disp 1999; 27: 1505-11.
28. Furlanetto TW, Nunes Jr RB, Sopelsa AMI, Machiel RMB. Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells. Braz J Med Biol Res 2001; 34: 259-63.
29. Furlanetto TW, Nguyen LQ, Jameson JL. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999; 140: 5705-11.
30. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocri Met 2001; 86: 1072-7.
31. Fujimoto N, Sakai Y, Ito A. Increase in estrogen receptor levels in MNU-induced thyroid tumors in LE rats. Carcinogenesis 1992; 13: 1315-8.
32. Thiruvengadam A, Govindarajulu P, Aruldhas MM. Modulatory effect of estradiol and testosterone on the development of N-nitrosodiisopropanolamine induced thyroid tumors in female rats. Endocr Res 2003; 29: 43-51.